Feasibility and Acceptability of Oxygen Saturation Monitoring Using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

10 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-20

Study Completion Date

2024-02-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This Clinical Trial will evaluate the Feasibility and Acceptability of Oxygen Saturation Monitoring using Masimo SafetyNet Alert (MSNA) in a Supportive Housing Program

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Mobile Monitoring of Vital Signs in Opioid Users

NCT02647073

Opioid Use Disorders

WITHDRAWN NA

PEX010-Assisted Therapy for Opioid Use Disorder (OUD): a Feasibility Study

NCT06608459

Opioid Use Disorder

NOT_YET_RECRUITING PHASE2

Targeted Naltrexone to Support Individuals Participating in Dry January

NCT07132177

Alcohol Misuse

RECRUITING PHASE2

Pharmacogenetics of Naltrexone for Stimulant Abuse

NCT03226223

Substance Use Disorders Methamphetamine Abuse

COMPLETED PHASE2

Evaluation of Intranasal Naltrexone and Naloxone

NCT03851731

Opioid-use Disorder

COMPLETED PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Opioid Use

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DEVICE_FEASIBILITY

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Masimo SafetyNet Alert (MSNA)

All subjects who are enrolled into the test group (excluding staff participants) and participate in data collection receive the noninvasive Masimo SafetyNet Alert (MSNA)

Group Type EXPERIMENTAL

Masimo SafetyNet Alert (MSNA)

Intervention Type DEVICE

This study will explore the feasibility of implementing the Masimo SafetyNet Alert (MSNA) oxygen saturation monitoring system and the acceptance of MSNA by individuals living in a supportive housing program, who inject opioids.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Masimo SafetyNet Alert (MSNA)

This study will explore the feasibility of implementing the Masimo SafetyNet Alert (MSNA) oxygen saturation monitoring system and the acceptance of MSNA by individuals living in a supportive housing program, who inject opioids.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants who are18 years of age or greater
* Participants housed within a supportive housing program who intend to inject opioids
* Participants who have given verbal informed consent to participate in the study

* Participant is research staff and/or Rita Thompson Residence staff
* Participant is willing to give implied consent by reading and completing the staff survey

Exclusion Criteria

* Participants deemed not suitable for the study at the discretion of the principal investigator, research staff or housing program nurses/staff
* Participants with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as psoriasis, eczema, angioma, burns, scar tissue, substantial skin breakdown, nail polish, acrylic nails, infections, or other abnormalities that may interfere with MSNA functioning
* Participants with known allergic reactions to foam/rubber products and/or adhesive tape

-None

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes